1699 Results

People

  1. Kris
    Kris
  2. Hudis
    Hudis
  3. De Angelis
    De Angelis
  4. Wolden
    Wolden
  5. Lee
    Lee
  6. Ahles
    Ahles
  7. Abrey
    Abrey
  8. Yahalom
    Yahalom
  9. Ilson
    Ilson
  10. Pfister
    Pfister

Groups

  1. Department of Medicine (769)
  2. Solid Tumor Oncology Division (598)
  3. Survivorship Research (395)
  4. Surgery (391)
  5. Center for Hematologic Malignancies (183)
  6. Radiation Oncology, Department of (181)
  7. Epidemiology and Biostatistics (178)
  8. Hematologic Malignancies, Division of (173)
  9. Population Sciences Research Program (173)
  10. GSK Faculty (157)
  1. "chemotherapy"
Formats
  1. Journal Article (1467)
  2. Review (90)
  3. Book Section (48)
  4. Conference Paper (28)
  5. Meeting Abstract (22)
  6. Editorial (18)
  7. Guidelines (17)
  8. Research Letter (5)
  9. Correspondence (2)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Department of Medicine (769)
  2. Solid Tumor Oncology Division (598)
  3. Survivorship Research (395)
  4. Surgery (391)
  5. Center for Hematologic Malignancies (183)
  6. Radiation Oncology, Department of (181)

More Groups

People
  1. Mark Kris (48)
  2. Clifford Hudis (45)
  3. Lisa De Angelis (43)
  4. Suzanne Wolden (42)
  5. Nancy Lee (40)
  6. Dean Bajorin (35)

More People

Years
  1. 2025 (31)
  2. 2024 (97)
  3. 2023 (67)
  4. 2022 (67)
  5. 2021 (77)
  6. 2020 (73)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (116)
  2. Cancer (94)
  3. Journal of Clinical Oncology (91)
  4. Journal of the National Comprehensive Cancer Network (50)
  5. Annals of Oncology (39)
  6. Journal of Neuro-Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (332)
  2. Springer (159)
  3. Wiley Blackwell (143)
  4. American Society of Clinical Oncology (97)
  5. Oxford University Press (94)
  6. Lippincott Williams & Wilkins (79)

More Publishers

Results (1699)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A study to learn how well enfortumab vedotin (EV) with pembrolizumab works and how safe it is in people with advanced urothelial cancer: A plain language summary of the EV-302/KEYNOTE-A39 study
    Editorial

    Powles, T.; Valderrama, B. P.; Gupta, S.; Bedke, J.; Kikuchi, E.; Hoffman-Censits, J.; Iyer, G.; Vulsteke, C.; Park, S. H.; Shin, S. J.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Cancer care telehealth access needs in underrepresented patients: Development and implementation of the pragmatic access to telehealth needs assessment survey
    Journal Article

    Gany, F.; Menon, L.; Finik, J.; Kakade, A.; Wu, M.; Ramirez, L.; Abumusallam, J.; Gomez, T.; Shahid, Z.
    Patient Education and Counseling (2025)

    Fulltext@MSK | Save
  • Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance
    Journal Article

    Takao, S.; Morell, V.; Uni, M.; Slavit, A.; Rha, S.; Cheng, S.; Schmalbrock, L. K.; Brown, F. C.; Beneyto-Calabuig, S.; Koche, R. P.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Treatment, toxicity, and mortality after subsequent breast cancer in female survivors of childhood cancer
    Journal Article

    Im, C.; Hasan, H.; Stene, E.; Monick, S.; Rader, R. K.; Sheade, J.; Wolfe, H.; Lu, Z.; Spector, L. G.; McDonald, A. J.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer
    Editorial

    Chi, K. N.; Rathkopf, D.; Smith, M. R.; Efstathiou, E.; Attard, G.; Olmos, D.; Lee, J. Y.; Small, E. J.; Pereira de Santana Gomes, A. J.; Roubaud, G.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Circulating tumor DNA and response to cisplatin-based chemotherapy in patients with metastatic urothelial carcinoma enrolled in CALGB 90601 (Alliance)
    Journal Article

    Guercio, B. J.; Whiting, K.; Shah, R. H.; Ballman, K. V.; Halabi, S.; Regazzi, A. M.; Milbank, J. H.; Bajorin, D. F.; Beltran, H.; Morris, M. J.; more...
    European Urology Open Science (2025)

    Fulltext@MSK | Save
  • Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Journal Article

    Shahid, S.; Prockop, S. E.; Flynn, G. C.; Mauguen, A.; White, C. O.; Bieler, J.; McAvoy, D.; Hosszu, K.; Cancio, M. I.; Jakubowski, A. A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Retrospective analysis of BRCA-altered uterine sarcoma treated with poly(ADP-ribose) polymerase inhibitors
    Journal Article

    Rao, M.; Merrill, M.; Troxel, M.; Chiang, S.; Momeni-Boroujeni, A.; Hensley, M. L.; Schram, A. M.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: A cell therapy consortium real-world analysis
    Journal Article

    Riedell, P. A.; Grady, C. B.; Nastoupil, L. J.; Luna, A.; Ahmed, N.; Maziarz, R. T.; Hu, M.; Brower, J.; Hwang, W. T.; Schuster, S. J.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Executive summary of the American Radium Society Appropriate Use Criteria for management of squamous cell carcinoma of the cervical esophagus: Systematic review and guidelines
    Guidelines

    Williams, V. M.; Hallemeier, C. L.; Jethwa, K. R.; Selfridge, J. E.; Shah, P.; Anker, C. J.; Abood, G.; Akselrod, D.; Berlin, J.; Kim, E.; more...
    American Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save